Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase

doi:10.3748/wjg.v13.i32.4328

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2918)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

331

HTML

2369

Figures (1-5)

218

Sum=2918

Aug 28, 2007 (publication date) through Aug 26, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Aug 28, 2007; 13(32): 4328-4332
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4328

Full Size Figure Download Figure

Figure 2 Hepatic function changes of each group. A: the level of ALT after Cystamine treatment; B: the level of TB after Cystamine treatment; C: the level of TBA after Cystamine treatment. ^bP < 0.01 vs Control; ^dP < 0.01 vs Fibrosis.

Citation: Qiu JF, Zhang ZQ, Chen W, Wu ZY. Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase. World J Gastroenterol 2007; 13(32): 4328-4332
URL: https://www.wjgnet.com/1007-9327/full/v13/i32/4328.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i32.4328